Novo Nordisk's Weight Loss Empire Stumbles: How CagriSema's Underperformance Triggered Market Turmoil and Leadership Shake-up
The pharmaceutical giant that revolutionized the weight loss market now finds itself on the defensive. After riding high on the success of its groundbreaking obesity medications, Novo Nordisk has suffered a significant setback that has cost the company billions in market value, triggered a leadership overhaul, and potentially reshaped the